LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Clinical trial NCT07288398 · RECRUITING

Trial details

NCT number: NCT07288398
Sponsor: Tenax Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension Associated With HFpEF

Start date: 2026-03-03
Primary completion: 2028-06-30
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.